Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT03044613||Active, not recruiting||Nivolumab +/- Relatlimab Prior to Chemoradiation Plus Nivolumab +/- Relatlimab With II/III Gastro/Esophageal Cancer||
||Other / Industry||
||25||All||18 Years and older (Adult, Older Adult)||NCT03044613||J1714
|July 11, 2017||February 2020||February 2025||February 7, 2017||October 14, 2019||